Drug Trial Radar · NCT03021499
Aurinia Renal Response in Active Lupus With Voclosporin
Last checked: Nov 19, 2026Latest source record: Mar 27, 2023 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
358
Actual
Start
May 17, 2017
Primary completion
Sep 24, 2019
Study completion Oct 10, 2019
Sponsor
- Lead sponsor
- Aurinia Pharmaceuticals Inc.Industry
- Sponsor type
- Industry
- First posted
- Jan 16, 2017
Design
- Study type
- Interventional
- Phase
- Phase 3
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Quadruple (participant, care provider, investigator, outcomes assessor)
- Primary purpose
- Treatment
- FDA-regulated drug
- Yes
- Who can join
- All sexes, from 18 years, up to 75 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
The purpose of this study is to assess the efficacy of voclosporin compared with placebo in achieving renal response after 52 weeks of therapy in subjects with active lupus nephritis.
Conditions
- Lupus Nephritis
Interventions
VoclosporinDrug
calcineurin inhibitor
Placebo Oral CapsuleDrug
matching placebo capsule
Primary outcomes
What the sponsor says the trial is designed to measure.
- Number of Participants With Adjudicated Renal Response at Week 52Time frame: 52 Weeks
Locations
185 sites in 31 countries. Site status is shown where the registry gives one.
AURORA Investigative Center
Huntsville, Alabama
AURORA Investigative Center
Phoenix, Arizona
AURORA Investigative Center
Phoenix, Arizona
AURORA Investigative Center
Beverly Hills, California
AURORA Investigative Center
Los Angeles, California
AURORA Investigative Center
Los Angeles, California
AURORA Investigative Center
Palo Alto, California
AURORA Investigative Center
Thousand Oaks, California
AURORA Investigative Center
Torrance, California
AURORA Investigative Center
Aurora, Colorado
AURORA Investigative Center
Denver, Colorado
AURORA Investigative Center
New Haven, Connecticut
AURORA Investigative Center
Clearwater, Florida
AURORA Investigative Center
DeBary, Florida
AURORA Investigative Center
Fort Lauderdale, Florida
AURORA Investigative Center
Fort Myers, Florida
AURORA Investigative Center
Miami, Florida
AURORA Investigative Center
Orlando, Florida
AURORA Investigative Center
Winter Park, Florida
AURORA Investigative Center
Atlanta, Georgia
AURORA Investigative Center
Columbus, Georgia
AURORA Investigative Center
Lawrenceville, Georgia
AURORA Investigative Center
Chicago, Illinois
AURORA Investigative Center
Louisville, Kentucky
AURORA Investigative Center
Baton Rouge, Louisiana
AURORA Investigative Center
New Orleans, Louisiana
AURORA Investigative Center
Boston, Massachusetts
AURORA Investigative Center
Detroit, Michigan
AURORA Investigative Center
Grand Blanc, Michigan
AURORA Investigative Center
Rochester, Minnesota
AURORA Investigative Center
St Louis, Missouri
AURORA Investigative Center
Las Vegas, Nevada
AURORA Investigative Center
Newark, New Jersey
AURORA Investigative Center
Great Neck, New York
AURORA Investigative Center
New York, New York
AURORA Investigative Center
New York, New York
AURORA Investigative Center
New York, New York
AURORA Investigative Center
Syracuse, New York
AURORA Investigative Center
Chapel Hill, North Carolina
AURORA Investigative Center
Charlotte, North Carolina
Showing 40 of 185 sites, US sites first. The full list is on the registry record.
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.